Literature DB >> 29078129

Age and the association of dementia-related pathology with trajectories of cognitive decline.

Willemijn J Jansen1, Robert S Wilson2, Pieter Jelle Visser3, Sukriti Nag4, Julie A Schneider5, Bryan D James6, Sue E Leurgans7, Ana W Capuano7, David A Bennett7, Patricia A Boyle8.   

Abstract

The association of dementia-related pathologies with cognition is hypothesized to decrease as age advances. We examined this in 413 persons without cognitive impairment at baseline who completed annual cognitive evaluations during a mean of 10.4 years. After death, neuropathologic examinations quantified beta amyloid plaque load, neurofibrillary tangles, and transactive response DNA-binding protein 43 pathology, and identified Lewy bodies, hippocampal sclerosis, and gross and microscopic cerebral infarcts. We tested whether age at death modified associations of these neuropathologies with the nonlinear trajectory of cognitive decline using mixed-effects change point models. The rate of global cognitive decline was gradual at first and then increased approximately 10-fold in the last 3 years of life. After adjustment for all other pathologic indices, tangle density, gross infarcts, Lewy bodies, and transactive response DNA-binding protein 43 were associated with global cognitive decline. However, the deleterious association of dementia-related pathologies with cognitive decline did not systematically vary by age. This suggests that the neuropathologic mechanisms underlying late-life cognitive decline do not substantially differ across the spectrum of age.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Cognitive decline; Dementia; Mixed-effects change point model; Neuropathologies

Mesh:

Substances:

Year:  2017        PMID: 29078129      PMCID: PMC5721665          DOI: 10.1016/j.neurobiolaging.2017.08.029

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  32 in total

1.  The BUGS project: Evolution, critique and future directions.

Authors:  David Lunn; David Spiegelhalter; Andrew Thomas; Nicky Best
Journal:  Stat Med       Date:  2009-11-10       Impact factor: 2.373

2.  Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly.

Authors:  Ira Driscoll; Susan M Resnick; Juan C Troncoso; Yang An; Richard O'Brien; Alan B Zonderman
Journal:  Ann Neurol       Date:  2006-12       Impact factor: 10.422

3.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

4.  A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease.

Authors:  C B Hall; R B Lipton; M Sliwinski; W F Stewart
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

5.  Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.

Authors:  Sukriti Nag; Lei Yu; Ana W Capuano; Robert S Wilson; Sue E Leurgans; David A Bennett; Julie A Schneider
Journal:  Ann Neurol       Date:  2015-04-22       Impact factor: 10.422

6.  Relation of neuropathology to cognition in persons without cognitive impairment.

Authors:  David A Bennett; Robert S Wilson; Patricia A Boyle; Aron S Buchman; Julie A Schneider
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

7.  Biracial population study of mortality in mild cognitive impairment and Alzheimer disease.

Authors:  Robert S Wilson; Neelum T Aggarwal; Lisa L Barnes; Julia L Bienias; Carlos F Mendes de Leon; Denis A Evans
Journal:  Arch Neurol       Date:  2009-06

8.  Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.

Authors:  Patricia A Boyle; Lei Yu; Sukriti Nag; Sue Leurgans; Robert S Wilson; David A Bennett; Julie A Schneider
Journal:  Neurology       Date:  2015-11-04       Impact factor: 9.910

9.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06

10.  Prevalence of mixed pathologies in the aging brain.

Authors:  Jasmin Rahimi; Gabor G Kovacs
Journal:  Alzheimers Res Ther       Date:  2014-11-21       Impact factor: 6.982

View more
  14 in total

1.  Increased BBB permeability contributes to EGCG-caused cognitive function improvement in natural aging rats: pharmacokinetic and distribution analyses.

Authors:  Bin-Bin Wei; Ming-Yan Liu; Xin Zhong; Wei-Fan Yao; Min-Jie Wei
Journal:  Acta Pharmacol Sin       Date:  2019-05-15       Impact factor: 6.150

2.  Neuropathological lesions in the very old: results from a large Brazilian autopsy study.

Authors:  Claudia K Suemoto; Renata E P Leite; Renata E L Ferretti-Rebustini; Roberta D Rodriguez; Ricardo Nitrini; Carlos A Pasqualucci; Wilson Jacob-Filho; Lea T Grinberg
Journal:  Brain Pathol       Date:  2019-04-10       Impact factor: 6.508

3.  A Neurologist's Practical Approach to Cognitive Impairment.

Authors:  Philip W Tipton; Gregory S Day; Neill Graff-Radford
Journal:  Semin Neurol       Date:  2021-11-26       Impact factor: 3.420

4.  Angiotensin receptor blocker use is associated with upregulation of the memory-protective angiotensin type 4 receptor (AT4R) in the postmortem brains of individuals without cognitive impairment.

Authors:  Caglar Cosarderelioglu; Lolita S Nidadavolu; Claudene J George; Ruth Marx-Rattner; Laura Powell; Qian-Li Xue; Jing Tian; Esther S Oh; Luigi Ferrucci; Pervin Dincer; David A Bennett; Jeremy D Walston; Peter M Abadir
Journal:  Geroscience       Date:  2022-08-15       Impact factor: 7.581

5.  Amyloid-β Positivity Predicts Cognitive Decline but Cognition Predicts Progression to Amyloid-β Positivity.

Authors:  Jeremy A Elman; Matthew S Panizzon; Daniel E Gustavson; Carol E Franz; Mark E Sanderson-Cimino; Michael J Lyons; William S Kremen
Journal:  Biol Psychiatry       Date:  2020-01-07       Impact factor: 13.382

Review 6.  Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.

Authors:  Thomas G Beach; Michael Malek-Ahmadi
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  Complex Profiles of Cerebrovascular Disease Pathologies in the Aging Brain and Their Relationship With Cognitive Decline.

Authors:  Melissa Lamar; Sue Leurgans; Alifiya Kapasi; Lisa L Barnes; Patricia A Boyle; David A Bennett; Konstantinos Arfanakis; Julie A Schneider
Journal:  Stroke       Date:  2021-10-04       Impact factor: 7.914

9.  Neuropathologic burden and the degree of frailty in relation to global cognition and dementia.

Authors:  Lindsay M K Wallace; Olga Theou; Sultan Darvesh; David A Bennett; Aron S Buchman; Melissa K Andrew; Susan A Kirkland; John D Fisk; Kenneth Rockwood
Journal:  Neurology       Date:  2020-09-28       Impact factor: 9.910

10.  Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging.

Authors:  Alifiya Kapasi; Lei Yu; Patricia A Boyle; Lisa L Barnes; David A Bennett; Julie A Schneider
Journal:  Neurology       Date:  2020-08-04       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.